Form 8-K Tobira Therapeutics, For: Nov 10

Go back to Form 8-K Tobira Therapeutics, For: Nov 10

Tobira Therapeutics (TBRA) Reports Q3 Loss of $1.22/Share

November 10, 2015 4:40 PM EST

Tobira Therapeutics (NASDAQ: TBRA) reported Q3 EPS of ($1.22), versus ($7.29) reported last year.

For earnings history and earnings-related data on Tobira Therapeutics (TBRA) click here.

... More